MedTrace Logo

Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.

NCT00729599 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2009-03-04

No results posted yet for this study

Summary

To prove the safety, in normal conditions, of the Cepacol Teen, a formulation to odontological usage.

Conditions

  • Hygiene

Interventions

DRUG

Cetylpyridinium chloride

Cetylpyridinium chloride during 21 consecutive days.

Sponsors & Collaborators

Principal Investigators

  • Jaderson Lima, MD · Sanofi-aventis administrative office Brazil

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2008-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00729599 on ClinicalTrials.gov